Kojin Therapeutics
Boston, United States · $60.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Total Funding
- $60.0M
- Last Round
- $60.0M Series AJun 2021
- Rounds
- 1
About
Biopharmaceutical company developing novel therapeutics based on ferroptosis and cell state biology.
Summary
Kojin Therapeutics is a Biotech company based in Boston, United States. It has raised $60.0M in total across 1 round, most recently a $60.0M Series A round in Jun 2021. Investors include Polaris Partners, Newpath Management and Cathay Health.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2021
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company